Both SEPT2 and MLL are down-regulated in MLL-SEPT2 therapy-related myeloid neoplasia

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Cerveira, Nuno ^a   Santos, Joana ^a   Bizarro, Susana ^a   Costa, Vera ^a   Ribeiro, Franclim R ^a   Lisboa, Susana ^a   Correia, Cecília ^a   Torres, Lurdes ^a   Vieira, Joana ^a   Snijder, Simone ^b   Mariz, José M ^a   Norton, Lucília ^a   Mellink, Clemens H ^b   Buijs, Arjan ^c   Teixeira, Manuel R ^a,d  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

MIXED LINEAGE LEUKEMIA PROTEIN; SEPTIN; SEPTIN 2; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; DGTPASE; MLL PROTEIN, HUMAN; PHOSPHATASE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHROMOSOME BANDING PATTERN; CONTROLLED STUDY; CYTOGENETICS; DOWN REGULATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE FUSION; GENETIC ASSOCIATION; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SECOND CANCER;

DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; NEOPLASMS, SECOND PRIMARY; PHOSPHORIC MONOESTER HYDROLASES;

EID: 66949157646     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-147     Document Type: Article

References (39)

1. Weirich CS Erzberger JP Barral Y The septin family of GTPases: architecture and dynamics Nat Rev Mol Cell Biol 2008, 9:478-489. 10.1038/ nrm2407 18478031
2. Gladfelter AS Montagna C Seeking truth on Monte Verita. Workshop on the molecular biology and biochemistry of septins and septin function EMBO Rep 2007, 8:1120-1126. 2267226 17975554 10.1038/sj.embor.7401116
3. Joo E Surka MC Trimble WS Mammalian SEPT2 is required for scaffolding nonmuscle myosin II and its kinases Dev Cell 2007, 13:677-690. 10.1016/ j.devcel.2007.09.001 17981136
4. Hall PA Russell SE The pathobiology of the septin gene family J Pathol 2004, 204:489-505. 10.1002/path.1654 15495264
5. Cerveira N Correia C Bizarro S Pinto C Lisboa S Mariz JM Marques M Teixeira MR SEPT2 is a new fusion partner of MLL in acute myeloid leukemia with t(2;11)(q37;q23) Oncogene 2006, 25:6147-6152. 10.1038/ sj.onc.1209626 16682951
6. van Binsbergen E de Weerdt O Buijs A A new subtype of MLL-SEPT2 fusion transcript in therapy-related acute myeloid leukemia with t(2;11)(q37;q23): A case report and literature review Cancer Genet Cytogenet 2007, 176:72-75. 10.1016/j.cancergencyto.2007.04.001 17574968
7. Snijder S Mellink CH Lelie van der H Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia Cancer Genet Cytogenet 2008, 180:149-152. 10.1016/ j.cancergencyto.2007.10.003 18206542
8. Cerveira N Santos J Pinheiro M Snijder S Lelie van der H Mellink C Teixeira MR A novel MLL-SEPT2 fusion variant in therapy-related myelodysplastic syndrome Cancer Genet Cytogenet 2008, 185:62-64. 10.1016/ j.cancergencyto.2008.05.002 18656699
9. Megonigal MD Rappaport EF Jones DH Williams TM Lovett BD Kelly KM Lerou PH Moulton T Budarf ML Felix CA t(11;22)(q23;q11.2) in acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes Proc Natl Acad Sci USA 1998, 95:6413-6418. 27754 9600980 10.1073/pnas.95.11.6413
10. Osaka M Rowley JD Zeleznik-Le NJ MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25) Proc Natl Acad Sci USA 1999, 96:6428-6433. 26898 10339604 10.1073/pnas.96.11.6428
11. Taki T Ohnishi H Shinohara K Sako M Bessho F Yanagisawa M Hayashi Y AF17q25, a putative septin family gene, fuses the MLL gene in acute myeloid leukemia with t(11;17)(q23;q25) Cancer Res 1999, 59:4261-4265. 10485469
12. Ono R Taki T Taketani T Kawaguchi H Taniwaki M Okamura T Kawa K Hanada R Kobayashi M Hayashi Y SEPTIN6, a human homologue to mouse Septin6, is fused to MLL in infant acute myeloid leukemia with complex chromosomal abnormalities involving 11q23 and Xq24 Cancer Res 2002, 62:333-337. 11809673
13. Kojima K Sakai I Hasegawa A Niiya H Azuma T Matsuo Y Fujii N Tanimoto M Fujita S FLJ10849, a septin family gene, fuses MLL in a novel leukemia cell line CNLBC1 derived from chronic neutrophilic leukemia in transformation with t(4;11)(q21;q23) Leukemia 2004, 18:998-1005. 10.1038/ sj.leu.2403334 14999297
14. Shaffer LG Tommerup N ISCN 2005 An International System for Human Cytogenetic Nomenclature Basel: Karger 1995.
15. van Dongen JJ Macintyre EA Gabert JA Delabesse E Rossi V Saglio G Gottardi E Rambaldi A Dotti G Griesinger F Parreira A Gameiro P Diaz MG Malec M Langerak AW San Miguel JF Biondi A Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia Leukemia 1999, 13:1901-1928. 10.1038/sj/leu/2401592 10602411
16. Chaplin T Bernard O Beverloo HB Saha V Hagemeijer A Berger R Young BD The t(10;11) translocation in acute myeloid leukemia (M5) consistently fuses the leucine zipper motif of AF10 onto the HRX gene Blood 1995, 86:2073-2076. 7662954
17. Poirel H Rack K Delabesse E Radford-Weiss I Troussard X Debert C Leboeuf D Bastard C Picard F Veil-Buzyn A Flandrin G Bernard O Macintyre E Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5 Blood 1996, 87:2496-2505. 8630416
18. Busson-Le Coniat M Salomon-Nguyen F Hillion J Bernard OA Berger R MLL-AF1q fusion resulting from t(1;11) in acute leukemia Leukemia 1999, 13:302-306. 10.1038/sj.leu.2401299 10025907
19. Shih LY Liang DC Fu JF Wu JH Wang PN Lin TL Dunn P Kuo MC Tang TC Lin TH Lai CL Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement Leukemia 2006, 20:218-223. 10.1038/sj.leu.2404024 16341046
20. Gabert J Beillard E Velden van der VH Bi W Grimwade D Pallisgaard N Barbany G Cazzaniga G Cayuela JM Cavé H Pane F Aerts JL De Micheli D Thirion X Pradel V González M Viehmann S Malec M Saglio G van Dongen JJ Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program Leukemia 2003, 17:2318-2357. 10.1038/ sj.leu.2403135 14562125
21. Beillard E Pallisgaard N Velden van der VH Bi W Dee R Schoot van der E Delabesse E Macintyre E Gottardi E Saglio G Watzinger F Lion T van Dongen JJ Hokland P Gabert J Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program Leukemia 2003, 17:2474-2486. 10.1038/sj.leu.2403136 14562124
22. Clark SJ Harrison J Paul CL Frommer M High sensitivity mapping of methylated cytosines Nucleic Acids Res 1994, 22:2990-2997. 310266 8065911 10.1093/nar/22.15.2990
23. Takai D Jones PA The CpG island searcher In Silico Biology 2003, 3:21.
24. Prestridge DS Predicting Pol II promoter sequences using transcription factor binding sites J Mol Biol 1995, 249:923-932. 10.1006/ jmbi.1995.0349 7791218
25. Eads CA Danenberg KD Kawakami K Saltz LB Blake C Shibata D Danenberg PV Laird PW MethyLight: A high-throughput assay to measure DNA methylation Nucleic Acids Res 2000, 28:E32. 102836 10734209 10.1093/nar/28.8.e32
26. Eads CA Lord RV Wickramasinghe K Long TI Kurumboor Sk Bernstein L Peters JH DeMeester SR DeMeester TR Skinner KA Laird PW Epigenetic patterns in the progression of esophageal adenocarcinoma Cancer Res 2001, 61:3410-3418. 11309301
27. Whitmann SP Liu S Vukosavljevic T Rush LJ Liu C Klisovic MI Maharry K Guimond M Strout MP Becknell B Dorrance A Klisovic RB Plass C Bloomfield CD Marcucci G Caligiuri MA The MLL partial tandem duplication: Evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy Blood 2005, 106:345-352. 1895129 15774615 10.1182/blood-2005-01-0204
28. Schreiner SA García-Cuéllar MP Fey GH Slany RK The leukemogenic fusion of MLL with ENL creates a novel transcriptional transactivator Leukemia 1999, 13:1525-1533. 10.1038/sj/leu/2401534 10516753
29. Zeisig BB Schreiner S García-Cuéllar MP Slany RK Transcriptional activation is a key function encoded by MLL fusion partners Leukemia 2003, 17:359-365. 10.1038/sj.leu.2402804 12592336
30. Esteller M Epigenetics in cancer N Engl J Med 2008, 358:1148-1159. 10.1056/NEJMra072067 18337604
31. Kinoshita M Kumar S Mizoguchi A Ide C Kinoshita A Haraguchi T Hiraoka Y Noda M Nedd5, a mammalian septin, is a novel cytoskeletal component interacting with actin-based structures Genes Dev 1997, 11:1535-1547. 10.1101/gad.11.12.1535 9203580
32. Spiliotis ET Kinoshita M Nelson WJ A mitotic septin scaffold required for Mammalian chromosome congression and segregation Science 2005, 307:1781-1785. 10.1126/science.1106823 15774761:
33. Kremer BE Haystead T Macara IG Mammalian septins regulate microtubule stability through interaction with the microtubule-binding protein MAP4 Mol Biol Cell 2005, 16:4648-4659. 1237071 16093351 10.1091/ mbc.E05-03-0267
34. Kremer BE Haystead T Macara IG Septins regulate actin organization and cell-cycle arrest through nuclear accumulation of NCK mediated by SOCS7 Cell 2007, 130:777-779. 10.1016/j.cell.2007.06.053 17803900
35. Elhasid R Sahar D Merling A Zivony Y Rotem A Ben-Arush M Izraeli S Bercovich D Larisch S Mitochondrial pro-apoptotic ARTS protein is lost in the majority of acute lymphoblastic leukemia patients Oncogene 2004, 23:5468-5475. 10.1038/sj.onc.1207725 15122323
36. Bennett KL Karpenko M Lin MT Claus R Arab K Dyckhoff G Plinkert P Herpel E Smiraglia D Plass C Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma Cancer Res 2008, 68:4494-4499. 10.1158/0008-5472.CAN-07-6509 18559491
37. Meyer C Schneider B Jakob S Strehl S Attarbaschi A Schnittger S Schoch C Jansen MWJC van Dongen JJM den Boer ML Pieters R Ennas M-G Angelucci E Koehl U Greil J Griesinger F zur Stadt U Eckert C Szczepañski T Niggli FK Schäfer BW Kempski H Brady HJM Zuna J Trka J Nigro LL Biondi A Delabesse E Macintyre E Stanulla M Schrappe M Haas OA Burmeister T Dingermann T Klingebiel T Marschalek R The MLL recombinome of acute leukemias Leukemia 2006, 20:777-784. 10.1038/sj.leu.2404150 16511515
38. DiMartino JF Miller T Ayton PM Landewe T Hess JL Clearly ML Shilatifard A A carboxy-terminal domain of ELL is required and sufficient for immortalization of myeloid progenitors by MLL-ELL Blood 2000, 96:3887-3893. 11090074
39. DiMartino JF Ayton PM Chen EH Naftzger CC Young BD Clearly ML The AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10 Blood 2002, 99:3780-3785. 10.1182/ blood.V99.10.3780 11986236